ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung

Ramesh S Gopal; Sarita Dubey; Kenneth E Rosenzweig; Joe Yujiao Chang; Roy Decker; Richard M Gewanter; Feng-Ming Kong; Brian E Lally; Corey J Langer; Hoon Ku Lee; Benjamin Movsas

doi:10.1016/j.ijrobp.2010.07.028

ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):969-74. doi: 10.1016/j.ijrobp.2010.07.028. Epub 2010 Aug 31.

Authors

Ramesh S Gopal¹, Sarita Dubey, Kenneth E Rosenzweig, Joe Yujiao Chang, Roy Decker, Richard M Gewanter, Feng-Ming Kong, Brian E Lally, Corey J Langer, Hoon Ku Lee, Benjamin Movsas

Affiliation

¹ University of Texas M D Anderson Cancer Center, Houston, TX, USA. rgopal@mdanderson.org

PMID: 20813465
DOI: 10.1016/j.ijrobp.2010.07.028

Abstract

"The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply society endorsement of the final document."

Publication types

Practice Guideline
Review

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / radiotherapy
Carcinoma, Non-Small-Cell Lung* / surgery
Chemotherapy, Adjuvant
Humans
Lung Neoplasms* / drug therapy
Lung Neoplasms* / pathology
Lung Neoplasms* / radiotherapy
Lung Neoplasms* / surgery
Neoadjuvant Therapy / methods
Neoplasm Staging
Postoperative Care / methods
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic
Remission Induction
Societies, Medical
United States